Skip to content
Delayed ~15 min

ALKS ALKERMES

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 22 analyst firms say about ALKERMES: their latest ratings, price targets and how far the stock is from them. How it works

45.90 USD+1.36 (+3.05%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+23.7%to the avg target 56.78 USD+10.88 USD
Buy 17 · Hold 5 · Sell 1

23 rated views · 24 analyst/firm records · 22 firms

Latest report4 Nov 2026avg report date 31 Jul
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8055
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8059

Recent analyst activity · last 90 days

Our tracked history has 14 reports on ALKS from 11 analyst firms in the last 90 days (22 firms in the past year).

Comparing each firm's latest target with its previous one: 5 raised their price target, 3 left it unchanged and 3 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: RBC Capital raised its target from $56.00 (set 9 Jun 2026) to $57.00 on 4 Nov 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BairdJoel BeattyBuy22 Sep 202661.00 USD
BairdLuke HerrmannBuy22 Sep 202661.00 USD
Bank of America SecuritiesJason GerberrySell29 Jun 202638.00 USD
Cantor FitzgeraldPete StavropoulosBuy12 Mar 202643.00 USD
Deutsche BankDavid HoangBuy13 Nov 202545.00 USD
Evercore ISIUmer RaffatBuy1 Jul 2026—
Goldman SachsAndrea NewkirkHold24 Sep 202650.00 USD
H.C. WainwrightDouglas TsaoHold21 Sep 2026Conflicting reports · excluded
JefferiesAkash TewariBuy17 Sep 202683.00 USD
JPMorganJessica FyeHold29 Jul 202661.00 USD
Leerink PartnersMarc GoodmanHold21 Jul 2026Conflicting reports · excluded
MizuhoGraig SuvannavejhBuy16 Sep 202665.00 USD
MizuhoUy EarBuy16 Sep 2026—
NeedhamAmi FadiaBuy21 Sep 202662.00 USD
Piper SandlerDavid AmsellemBuy5 Aug 202665.00 USD
RBC Capital MarketsLeonid TimashevBuy22 Sep 2026Conflicting reports · excluded
StifelPaul MatteisBuy20 Jul 202663.00 USD
TD CowenJoseph ThomeBuy4 Nov 202660.00 USD
TruistAlex NackenoffBuy16 Oct 202655.00 USD
UBSAshwani VermaBuy6 May 202648.00 USD
Weiss RatingsUnnamed analyst—7 Aug 2026—
Wells FargoBenjamin BurnettBuy4 Nov 202668.00 USD
Wolfe ResearchRudy LiBuy22 Sep 202650.00 USD
Data feed RESEARCHResearch TeamHold27 Apr 202644.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 02:36 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.